Arcadia Biosciences
From Wikipedia, the free encyclopedia
 | |
| Company type | Public |
|---|---|
| Nasdaq: RKDA | |
| Industry | agricultural biotechnology |
| Founded | 2002 |
| Headquarters | Davis, California, United States |
Area served | Worldwide |
Key people | Matthew Plavan (Chief Executive Officer) |
| Products | GoodWheat™ |
| Revenue | |
Number of employees | 42[1] |
| Website | arcadiabio |
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity.[2][3] The company is partly owned by Moral Compass Corporation.[4]
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat.[5][6][7] Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017.[8][9] HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.[10]
